China Universal Asset Management Company’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.02M	Buy	27,266 +1,999	+8%	+$680K	0.68%	35
2025 Q4	$10M	Buy	25,267 +2,480	+11%	+$1.1M	0.77%	28
2025 Q3	$10.4M	Sell	22,787 -5,030	-18%	-$2.05M	0.86%	22
2025 Q2	$9.07M	Sell	27,817 -3,154	-10%	-$873K	0.85%	24
2025 Q1	$8.36M	Sell	30,971 -8,026	-21%	-$2.06M	0.78%	22
2024 Q4	$9.18M	Buy	38,997 +2,657	+7%	+$699K	0.86%	22
2024 Q3	$9.99M	Buy	36,340 +9,831	+37%	+$2.56M	1.1%	18
2024 Q2	$6.44M	Sell	26,509 -9,313	-26%	-$1.47M	0.91%	31
2024 Q1	$5.35M	Buy	35,822 +9,662	+37%	+$1.61M	0.68%	39
2023 Q4	$5.01M	Buy	26,160 +22,580	+631%	+$3.85M	0.97%	26
2023 Q3	$634K	Sell	3,580 -9,492	-73%	-$1.81M	0.18%	100
2023 Q2	$2.48M	Buy	13,072 +9,868	+308%	+$1.96M	0.77%	39
2023 Q1	$642K	Sell	3,204 -10,400	-76%	-$2.19M	0.22%	85
2022 Q4	$3.23M	Buy	13,604 +12,480	+1,110%	+$2.66M	1.3%	21
2022 Q3	$225K	Buy	+1,124	New	+$214K	0.09%	92